- Posts by Kelsey J. McElveen
OfficerAs a member of the firm’s Intellectual Property Litigation group, Kelsey focuses her practice on patent litigation under the Hatch-Waxman Act. After nearly a decade of experience working on Abbreviated New Drug Application ...
The U.S. Supreme Court recently issued its decision in Amgen Inc. v. Sanofi; a decision long-awaited by patent practitioners. In its decision, the Court unanimously held that several of Amgen’s patent claims to a class of antibodies were invalid for lack of enablement.
- EventHealth Law Webinar – Strategic Deals and Innovative Business Arrangements for Health Care Organizations
- Legal UpdateInternational Travel Advisory During the Holiday Season and the Incoming Trump Administration
- Legal UpdateDOL and USCIS Release Rule for Supplemental H-2B Visa Numbers for FY 2025
- EventHealth Law Webinar – The Annual Regulatory Update 2024